Avidity Biosciences - 51 Year Dividend History | RNA

Historical dividend payout and yield for Avidity Biosciences (RNA) since 1971. The current TTM dividend payout for Avidity Biosciences (RNA) as of May 27, 2022 is $0.00. The current dividend yield for Avidity Biosciences as of May 27, 2022 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.728B $0.009B
Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio